Skip to main content

Day: August 24, 2022

CE Brands Announces Normal Course Issuer Bid

CALGARY, Alberta, Aug. 24, 2022 (GLOBE NEWSWIRE) — CE BRANDS INC. (“CE Brands” or the “Corporation”) (TSX-V: CEBI; CEBI.WT) is pleased to announce that it will conduct a Normal Course Issuer Bid (“NCIB”) to purchase for cancellation, during the 12-month period starting August 30, 2022, up to 1,263,027 of the outstanding common shares of the Corporation (the “Common Shares”), representing 5% of the Common Shares outstanding. The program will end on August 29, 2023 unless the maximum amount of Common Shares is purchased before then or CE Brands provides earlier notice of termination. The purchase and payment for the Common Shares will be made by CE Brands through the facilities of the TSX Venture Exchange or alternative trading systems. Integral Wealth Securities Limited has been selected as CE Brands’ agent for the NCIB. The price...

Continue reading

Whoa Dough Soars with American Airlines Bringing Plant-Based, Gluten-Free Cookie Dough Bars to Passengers

World’s Largest Airline Now Offers First-Class Passengers a Tasty, Better-for-You, Vegan Snack OptionWhoa Dough plant based, gluten free cookie dough bars are now being distributed in American Airlines’ first-class baskets Whoa Dough founder, Todd Goldstein, scores a deal with American AirlinesHIGHLAND HEIGHTS, Ohio, Aug. 24, 2022 (GLOBE NEWSWIRE) — Whoa Dough, the maker of a delicious line of plant-based, on-the-go cookie dough bars, is taking to the skies as the popular gluten-free snack will now be available for American Airlines first-class passengers on domestic flights. “Skies really is the limit for Whoa Dough now that American Airlines, the largest airline in the world, will be offering first-class passengers our tasty, plant-based snack bars that are also gluten-free,” stated Todd Goldstein, founder of Whoa Dough....

Continue reading

DrivenIQ Raises $15 Million in Series A Funding Backed by Capstone Technologies Group, Inc.

DrivenIQ DrivenIQDrivenIQ DrivenIQTOWSON, Md., Aug. 24, 2022 (GLOBE NEWSWIRE) — DrivenIQ, the experts in audience data and advertising technologies, has raised $15 million in a Series A funding round backed by Capstone Technologies Group, Inc. (OTC: CATG). Capstone Technologies acquires, operates and organically develops disruptive technologies. The company acquired an initial minority interest in DrivenIQ in October 2021 and has since invested additional capital to further accelerate DrivenIQ’s growth. Founded by industry veteran Albert Thompson, DrivenIQ specializes in helping brands unify, collect, normalize and ingest consumer data – easily and seamlessly – to better engage with their ideal customers. In the first six months of 2022, DrivenIQ has more than doubled its monthly revenue, and in July 2022 alone,...

Continue reading

Internet of Vehicles Market to Hit Sales of 448.16 billion by 2028 | Internet-connected vehicles to Save Up to $8.4 Billion in Manufacturing Costs Over the Next 10 Years | SkyQuest

Global internet of vehicles market was valued at USD 95.62 billion in 2021, and it is expected to reach a value of USD 448.16 billion by 2028, at a CAGR of 21.3% over the forecast period (2022–2028). Westford, USA, Aug. 24, 2022 (GLOBE NEWSWIRE) — Internet of Vehicles Market to Hit Sales of 448.16 billion by 2028 | Internet-connected vehicles to Save Up to $8.4 Billion in Manufacturing Costs Over the Next 10 Years | SkyQuest Global internet of vehicles market was valued at USD 95.62 billion in 2021, and it is expected to reach a value of USD 448.16 billion by 2028, at a CAGR of 21.3% over the forecast period (2022–2028). Modern automobiles come with plenty of features, but the ability to stay connected to the Internet is something that often falls by the wayside. However, that is starting to change as more and more drivers take...

Continue reading

Machine Learning Market to hit sales of $164.05 billion | Machine Learning is Become Essential for Decision Making and Data Pre-processing

Global machine learning market was valued at US$ 16.2 billion in 2021, and it is expected to reach a value of US$ 164.05 billion by 2028, at a CAGR of more than 39.2% over the forecast period (2022–2028). Westford, USA, Aug. 24, 2022 (GLOBE NEWSWIRE) — Machine learning has been rapidly growing in popularity and adoption over the past few years, with many companies now employing it to aide in their various business needs. This growth has been seen across a variety of industries, including marketing, finance, technology, and healthcare. It is now becoming essential for businesses of all sizes to understand machine learning and how it can be used to improve their efficiency and effectiveness. For starters, machine learning can be used to analyze large data sets quickly and accurately. This allows businesses to make better decisions...

Continue reading

Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction Treatment

The dedicated treatment indicated a significant decrease in cocaine craving in a sub- group that received Clearmind’s MEAI VANCOUVER, Aug. 24, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND), (OTC Pink: CMNDF), (FSE: CWY0) (“Clearmind” or the “company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced additional positive pre-clinical results for treatment for cocaine addiction using MEAI, its novel psychedelic molecule. “We are very excited by these new results which further strengthen our previous results indicating the potential of our proprietary MEAI to treat cocaine addiction,” said Dr. Adi Zuloff-Shani, Clearmind’s Chief Executive Officer. “As cocaine is extremely addictive...

Continue reading

Brain Scientific Announces CE Mark Approval for NeuroCap™ Device

LAKEWOOD RANCH, Fla., Aug. 24, 2022 (GLOBE NEWSWIRE) — via InvestorWire — –– Brain Scientific (OTCQB:BRSF), a Florida-based medical device technology company, today announces receiving the Conformité Européenne (CE) Mark for the NeuroCap™. The CE mark confirms that Brain Scientific meets all European Medical Device Directive requirements to begin commercializing its innovative neurological devices across the European Continent and other CE mark geographies. “The CE mark approval is yet another certification proving the effectiveness of Brain Scientific’s technologies,” said Daniel Cloutier, CEO of LOK Corporation. “We have seen strong demand from European neurologists and distributors for the NeuroCap™, and now with the CE mark Brain Scientific can start selling to medical facilities in Europe.” “Our neurology products are...

Continue reading

Valoe Corporation’s Half-Year Financial Report 1 January – 30 June 2022

Valoe Corporation        Half-Year Financial Report         24 August 2022 at 17.20 Finnish time    THE FIRST HALF YEAR OF 2022 IN BRIEF During the reporting period January – June 2022, the net sales of Valoe Group, under the IFRS standards, was about EUR 0.5 million (in 2021: EUR 1.2 million). The EBITDA was EUR -1.8 million (EUR -0.9 million) and the EBIT EUR -2.7 million (EUR -1.7 million). The profit for the period was EUR -3.7 million (EUR -2.5 million). The undiluted earnings per share were EUR -0.01 (EUR -0.01) and the diluted earnings per share were EUR -0.01 (EUR -0.01). The working capital situation continued tight throughout the first half of the year 2022. In order to strengthen the working capital situation and the capital structure, we issued the Convertible Bond 1/2022 in April 2022. The Convertible Bond 1/2022 was subscribed...

Continue reading

Neuromodulation Devices Market to Hit Sales of $10.97 Billion By 2028 | Over 600 million People are Potential Consumers of Neuromodulation Devices | SkyQuest

Global neuromodulation devices market was valued at USD 5.88 billion in 2021, and it is expected to attain a value of USD 10.97 billion by 2028, at a CAGR of 9.3% over the forecast period (2022–2028). Westford USA, Aug. 24, 2022 (GLOBE NEWSWIRE) — Neuromodulation devices market is witnessing a growing demand for variety of implants, such as brain stimulators, deep brain stimulation (DBS), and spinal cord stimulators. In recent years, these devices have become increasingly popular for the treatment of neurodegenerative diseases, such as chronic pain, epilepsy, Parkinson’s and Alzheimer’s. Growing evidence suggests that these devices can improve symptoms and even slow or stop the progression of these diseases. SkyQuest estimates that globally more than 30 million people are suffering from some kind of neurological disorders and more...

Continue reading

Industrial Automation Market to Generate Revenue of $289 Billion by 2028 | Growing Adoption of AI and Machine Learning to Play Key Role

Global industrial automation market was valued at USD 150.2 billion in 2021, and it is expected to reach a value of USD 289.04 billion by 2028, at a CAGR of 9.8% over the forecast period (2022–2028). Westford, USA, Aug. 24, 2022 (GLOBE NEWSWIRE) — As the world becomes increasingly automated, businesses are turning to industrial automation solutions to help increase efficiency and productivity. By automating routine tasks and processes, businesses can free up workforce time to focus on more important duties. This growth of the industrial automation market is mainly due to the increasing demand for safe, reliable, and efficient manufacturing systems. These systems help manufacturers achieve increased output and reduce costs. As per SkyQuest’s findings, businesses save from 15 to 60% on worker costs, making it one of the most cost-effective...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.